Unknown

Dataset Information

0

Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing.


ABSTRACT:

Objectives

To describe Delta/Omicron SARS-CoV-2 variants co-infection detection and confirmation during the fifth wave of COVID-19 pandemics in France in 7 immunocompetent and epidemiologically unrelated patients.

Methods

Since December 2021, the surveillance of Delta/Omicron SARS-CoV-2 variants of concern (VOC) circulation was performed through prospective screening of positive-samples using single nucleotide polymorphism (SNP) PCR assays targeting SARS-CoV-2 S-gene mutations K417N (Omicron specific) and L452R (Delta specific). Samples showing unexpected mutational profiles were further submitted to whole genome sequencing (WGS) using three different primer sets.

Results

Between weeks 49-2021 and 02-2022, SARS-CoV-2 genome was detected in 3831 respiratory samples, of which 3237 (84.5%) were screened for VOC specific SNPs. Unexpected mutation profiles suggesting a dual Delta/Omicron population were observed in 7 nasopharyngeal samples (0.2%). These co-infections were confirmed by WGS. For 2 patients, the sequence analyses of longitudinal samples collected 7 to 11 days apart showed that Delta or Omicron can outcompete the other variant during dual infection. Additionally, for one of these samples, a recombination event between Delta and Omicron was detected.

Conclusions

This work demonstrates that SARS-CoV-2 Delta/Omicron co-infections are not rare in high virus co-circulation periods. Moreover, co-infections can further lead to genetic recombination which may generate new chimeric variants with unpredictable epidemic or pathogenic properties that could represent a serious health threat.

SUBMITTER: Combes P 

PROVIDER: S-EPMC9250411 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing.

Combes Patricia P   Bisseux Maxime M   Bal Antonin A   Marin Pierre P   Latour Justine J   Archimbaud Christine C   Brebion Amélie A   Chabrolles Hélène H   Regagnon Christel C   Lafolie Jérémy J   Destras Gregory G   Simon Bruno B   Izopet Jacques J   Laurence Josset   Henquell Cécile C   Mirand Audrey A  

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20220702 11


<h4>Objectives</h4>To describe Delta/Omicron SARS-CoV-2 variants co-infection detection and confirmation during the fifth wave of COVID-19 pandemics in France in 7 immunocompetent and epidemiologically unrelated patients.<h4>Methods</h4>Since December 2021, the surveillance of Delta/Omicron SARS-CoV-2 variants of concern (VOC) circulation was performed through prospective screening of positive-samples using single nucleotide polymorphism (SNP) PCR assays targeting SARS-CoV-2 S-gene mutations K41  ...[more]

Similar Datasets

| S-EPMC9581791 | biostudies-literature
| S-EPMC9451931 | biostudies-literature
| S-EPMC9588762 | biostudies-literature
| S-EPMC8930394 | biostudies-literature
| S-EPMC10763854 | biostudies-literature
| S-EPMC9734754 | biostudies-literature
| S-EPMC9030034 | biostudies-literature
| S-EPMC9055682 | biostudies-literature
| S-EPMC9350351 | biostudies-literature
| S-EPMC9273097 | biostudies-literature